Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

The use of intraventricular thrombolytics in intraventricular hemorrhage.

Nyquist P, Hanley DF

Neurology and Anesthesia Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore Maryland, 21287-7840, USA. pnyquis1@jhmi.edu

Intraventricular hemorrhage (IVH) is associated with a high mortality and morbidity. Patients with this disorder may now be offered the possibility of treatment. This treatment comes in the form of intraventricular thrombolytics. At present a large randomized trial is testing the efficacy of intraventricular rt-PA in IVH in the setting of intracranial hemorrhage (ICH) . Preliminary data suggests that it may be successful in patients with IVH in this setting. This trial is the accumulation of animal and human trials completed over the last 20 years.

Published 3 September 2007 in J Neurol Sci, 261(1): 84-8.
Full-text of this article is available online (may require subscription).

© 2004-2008 Chemotherapy Research Today. All Rights Reserved.